-
- Posted Wednesday March 6, 2013
Top Yankees' official supports TGen's groundbreaking fight against pancreatic cancer
Brian Cashman joins other prominent advocates on TGen's National Advisory Council for Pancreatic Cancer Research
PHOENIX, Ariz. - March 6, 2013 - A top official
of the New York Yankees whose father passed from pancreatic cancer
has joined a prestigious national panel organized by the
Translational Genomics Research Institute (TGen) to fight this
aggressive disease.
Brian Cashman, Senior Vice President and General Manager of the
vaunted Yankees Major League Baseball
franchise, has joined TGen's National Advisory Council for
Pancreatic Cancer Research.
TGen's National Advisory Council leads a critically needed funding
effort and promotes a deeper public understanding of pancreatic
cancer, the nation's fourth-leading cause of cancer death, which in
2012 took the lives of nearly 44,000 in the U.S. and nearly 235,000
worldwide.
Cashman lost his father, John, in September after a 10-month
battle with pancreatic cancer. He had wanted his Yankees to reach
the World Series as one last gift to his father.
"My father loved the Yankees. There are a lot of people who face
these kinds of challenges, and they look to the Yankees to provide
positive inspiration. For my father, the Yankees were always
something he could look forward to," he said."I welcome the
responsibilities and challenges of my role in the fight against
pancreatic cancer.I have a personal experience to draw from,
and coupled with my unique standing within the fabric of baseball,
I'd like to believe I can make the type of contribution my father
would be proud of."
Cashman was invited to join TGen's National Advisory Council by
another council member, Arizona Diamondbacks President and CEO
Derrick Hall, who in 2011 lost his father, Larry, to pancreatic
cancer, even as Derrick was fighting his own battle with prostate
cancer.
The Yankees and Diamondbacks played one of the game's iconic
7-game World Series in 2001.
In addition to Cashman and Hall, another MLB official, David
Dombrowski - President, CEO and General Manager of the Detroit
Tigers - also is a member of the National Advisory Council for
Pancreatic Cancer Research.
Other members of TGen's National Advisory Council are: Raymond
Bojanowski, Co-founder and Co-chairman of the Seena Magowitz
Foundation; Karl Glassman, Chief Operating Officer and Executive
Vice President of Leggett & Platt Inc.; Diane Halle, President
of the Bruce T. Halle Family Foundation and the Herbert K. Cummings
Charitable Trust; Steve Hilton, Chairman and Chief Executive
Officer of Meritage Homes Corp.; David Lane, President of the Lane
Affiliated Companies; Roger Magowitz, President and Founder of the
Seena Magowitz Foundation; Vincent McBeth, President of the The
McBeth Group International and a retired U.S. Navy Commander; Larry
Rogers, President and CEO of the Sealy Corp.; Steve Stagner,
President and CEO of the Mattress Firm; Louis A. "Chip" Weil III,
retired Chairman, President and CEO of Central Newspapers Inc.; and
Howard Young, President of the General Wholesale Company.
"Brian Cashman is a powerful addition to TGen's National Advisory
Council. His personal experience, championship reputation, and
national visibility will be a huge boost to TGen's fight against
pancreatic cancer," said Michael Bassoff, TGen Foundation
President.
Cashman joined the Yankees as a 19-year-old intern and now
commands one of the most demanding jobs in sports. During 25
seasons, he has earned five World Series rings. At age 30, he
became the youngest GM to win a World Series. And during 1998-2000
he became the only GM in Baseball history to win World Series
titles in each of his first three seasons.
# # #
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. Research at
TGen is focused on helping patients with diseases such as cancer,
neurological disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the
genetic components of common and complex diseases. Working with
collaborators in the scientific and medical communities, TGen
believes it can make a substantial contribution to the efficiency
and effectiveness of the translational process. For more
information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]